A

Aytu BioPharma
D

AYTU

1.76000
USD
0.05
(2.92%)
مغلق
حجم التداول
31
الربح لكل سهم
1
العائد الربحي
-
P/E
-1
حجم السوق
10,822,889
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    APT
    -0.04000
    (-0.73%)
    5.47000 USD
    C
    CODX
    0.04950
    (6.20%)
    0.84780 USD
    I
    INO
    0.06500
    (2.96%)
    2.26000 USD
    MRNA
    MRNA
    2.600
    (7.24%)
    38.490 USD
    O
    OPK
    -0.02500
    (-1.67%)
    1.47500 USD
    المزيد
الأخبار
المقالات

العنوان: Aytu BioPharma

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidityand a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.